This book is a continuum of the first two books published in the STEM CELLS series entitled "Stem Cells: From Drug to Drug Discovery" and "Stem Cells: From Hype to Real Hope" which were published in 2017 and 2019, respectively. The scope of the book encompasses a wide range of topics with a latitude from adult stem cells to pluripotent stem cells in regenerative medicine either alone or as part of the combinatorial therapeutic intervention approach as "drug" besides their application as tools (disease model) during drug development process. Written by a leading group of researchers, the book encompasses experimental to clinical aspects of stem/progenitors cells, their biology, and characteristics.

• Preface
• Contents
• Contributing authors
• List of abbreviations
• 1. Pluripotent stem-cell-derived corneal cells
• 2. Stem cells and lung cancer: between advanced diagnostics and new therapeutics
• 3. The significance of pericytes in health and disease: the role of pericytes with special focus on atherosclerosis
• 4. Bone stem cell therapy in the clinical perspective: a focus on nonrandomized and randomized trials
• 5. Influence of selected cryoprotectants on regeneration of cryopreserved cells properties
• 6. Molecular mechanisms of neural stem cells differentiation
• 7. Adrenomedullins and their emerging role in regenerative medicine
• 8. Mesenchymal stem cells and their role in hypoxia-induced injury
• Index